Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
BioXcel Therapeutics (BTAI) has been under persistent pressure in recent sessions, with the stock recently trading at $1.14—a decline of approximately 5.8% from the prior close. The move extends a period of choppy, low-confidence trading as the stock hovers near the lower end of its recent range. Su
BioXcel (BTAI) Stock: Down -5.79%, Support Test at $1.08 2026-05-15 - Shared Trade Alerts
BTAI - Stock Analysis
4549 Comments
1015 Likes
1
Deaudre
Community Member
2 hours ago
I understood it emotionally, not logically.
👍 294
Reply
2
Jenri
Insight Reader
5 hours ago
This feels like something I’ll think about later.
👍 248
Reply
3
Darricka
Active Contributor
1 day ago
Trading activity suggests a healthy market with balanced participation across various sectors.
👍 218
Reply
4
Bennard
Power User
1 day ago
This could’ve been useful… too late now.
👍 26
Reply
5
Alyssum
Registered User
2 days ago
Investor sentiment remains constructive, with broad-based gains supporting positive market momentum. Consolidation phases provide stability, and technical support levels are holding. Analysts recommend watching for breakout confirmation through volume and relative strength indicators.
👍 154
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.